Dr. Reddy's Laboratories Ltd. 500124 shares slid 5.01% to 1,224.70 Indian rupees Friday, on what proved to be an all-around ...

Shares of Dr Reddy's Laboratories fell by 5% as the company's third-quarter profit rise failed to impress investors. The ...

(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

Dr Reddy’s Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third ...

Dr Reddy’s Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...

Dr. Reddy's stock falls on Q3 fiscal 2025 results, wherein earnings match estimates but revenues beat the same.

Prabhudas Lilladher recommended reduce rating on Dr. Reddy's Laboratories with a target price of Rs 1335 in its research ...

The company's North American revenue has seen a decline of over 9%. One of the primary worries is the reduction in revenues ...

Most pharma stocks traded in the red during Friday’s session, with the Nifty Pharma index falling 2.19% at 21,854.15. Dr.

Donald Trump's swearing-in ceremony, Davos and Q3 earnings are among the major events that took place this week.

At close, Sensex fell 0.43 per cent at 76,190.46, while the Nifty declined 0.49 per cent, ending at 23,092.20. BSE MidCap and ...

The equity benchmarks witnessed sell-off on the last trading session of the week on January 24, with the Sensex plunging ...